Literature DB >> 7855782

Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients.

A J Azar1, J W Deckers, F R Rosendaal, P F van Bergen, F J van der Meer, J J Jonker, E Briët.   

Abstract

Various methods have been described to evaluate efficacy of anticoagulant therapy using the international normalized ratio (INR). We compared the following approaches: (1) total INR's or the most recent measurement; (2) percent time within therapeutic range, with INR changing directly or halfway between visits; and (3) total observation time assuming INR changing linearly. The study population comprised 1700 post myocardial infarction patients. Treatment comprised 3725 patient-years. There were 61,471 INR assessments with target therapeutic level of 2.8-4.8. Acenocoumarol as well as phenprocoumon were employed. Therapeutic achievement in the first months of treatment was low: less than 60% of INR's were in range. Treatment stabilized after 6 months. Patients on acenocoumarol were within range 70% of the time compared to 80% for phenprocoumon. Method 3 is preferred because it incorporates time and is capable of calculating incidence rates at different INR levels. Our findings call for an urgent improvement of standard of anticoagulant control in the first months following commencement of treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7855782

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Age and first INR after initiation of oral anticoagulant therapy with acenocoumarol predict the maintenance dosage.

Authors:  Johanna H H van Geest-Daalderop; Barbara A Hutten; Augueste Sturk; Marcel M Levi
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 2.  A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation.

Authors:  D A Fitzmaurice; P Kesteven; K M Gee; E T Murray; R McManus
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

3.  Evaluation of a primary care anticoagulant clinic. Reporting of results should be standardised.

Authors:  D A Fitzmaurice; F D Hobbs
Journal:  BMJ       Date:  1996-06-22

4.  Where should oral anticoagulation monitoring take place?

Authors:  F D Hobbs; D A Fitzmaurice
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

5.  A new regimen for starting warfarin therapy in out-patients.

Authors:  A Oates; P R Jackson; C A Austin; K S Channer
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 6.  Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis.

Authors:  Natalie Oake; Alison Jennings; Alan J Forster; Dean Fergusson; Steve Doucette; Carl van Walraven
Journal:  CMAJ       Date:  2008-07-29       Impact factor: 8.262

7.  Quality of oral anticoagulant therapy in patients who perform self management: warfarin versus phenprocoumon.

Authors:  Christina Friis Jensen; Thomas Decker Christensen; Marianne Maegaard; John Michael Hasenkam
Journal:  J Thromb Thrombolysis       Date:  2008-09-25       Impact factor: 2.300

8.  Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.

Authors:  L Schmitt; J Speckman; J Ansell
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 9.  Pharmacogenetics and anticoagulant therapy.

Authors:  Brian F Gage; Charles S Eby
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

10.  Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population.

Authors:  Gunnar H Nilsson; Ingela Björholt; Hans Johnsson
Journal:  BMC Fam Pract       Date:  2003-04-01       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.